Delay and lack of execution don't just mean increased dilution due to the low share price....it means other things to people that are suffering from diseases than Apabetalone could potentially help treat.  In some cases it could be life and death.  So while DM perhaps is holding out to get what he perceives to be fair market value, there are people on dialysis at extreme risk of a MAC event while waiting for a new Kidney...a gentleman across the street from me is in this situation, he already had bypass surgery.

Check out the Facebook Group for Muscular Dystrophy UK and read the comments from back in Feb when the news came out about potential treatment for those with that disease.  Its in the public domain so I'll paste it:

https://www.facebook.com/search/top/?q=apabetalone&ref=eyJzaWQiOiIwLjIwNjM3MjAzMTg0NzYwODU1IiwicXMiOiJKVFZDSlRJeVlYQmhZbVYwWVd4dmJtVWxNaklsTlVRIiwiZ3YiOiJiZWUwOWY5M2ZhNzMyY2ZhNTlhMWNiNmQ5ZjQ1MGQzODkyNDI0ZTQ5IiwiZW50X2lkcyI6W10sImJzaWQiOiI2ODNiNmYwMDBhYzQxMmI4ZjZlOWM2NGFlNWYxYTBhZCJ9

People asking when it will be available, kids asking family members if their form of MD is the one mentioned...others willing to volunteer for trials.  It tugs at the heart strings...